Ligand Pharmaceuticals LGND
NASDAQ LGND
$310.36 -3.74 (-1.19%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Operating Margin (2010 - 2026)

Updated

Ligand Pharmaceuticals (LGND) recorded Operating Margin of 13.49% in Q2 2026, down 4.24 percentage points from 17.73% a year earlier and down 20.09 percentage points from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Operating Margin (2010 - 2026) Analysis & Trends

On a TTM basis, Ligand Pharmaceuticals' Operating Margin came in at 32.61% as of Jun 30, 2026, up 50.87 percentage points year-over-year; for FY2025, it was 15.29%, up 28.82 percentage points from FY2024.

  • Annual Operating Margin has a five-year change of -7.63 percentage points (FY2020 to FY2025).
  • Across earlier years, Operating Margin came in at -13.53% in FY2024 (-22.62 pp), 9.09% in FY2023 (+7.55 pp), 1.55% in FY2022 (-41.45 pp) and 42.99% in FY2021 (+20.07 pp).
  • The Q2 2026 figure is the lowest quarterly Operating Margin since Q1 2025.
  • On a year-over-year basis, Operating Margin rose in four of the last eight quarters, with an average year-over-year change of +19.60 percentage points.
  • Peak year-over-year performance for Operating Margin in the last five years was a gain of 113.47 percentage points in Q1 2026, against a drop of 106.71 percentage points in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at 33.58% (Q1 2026), 23.20% (Q4 2025) and 47.58% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Ligand Pharmaceuticals 6.26 Bn 2.72 Bn - 13.49%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.49%
Mar 31, 2026 33.58%
Dec 31, 2025 23.20%
Sep 30, 2025 47.58%
Jun 30, 2025 17.73%
Mar 31, 2025 -79.89%
Dec 31, 2024 -22.51%
Sep 30, 2024 6.07%
Jun 30, 2024 -45.99%
Mar 31, 2024 9.65%
Dec 31, 2023 -11.95%
Sep 30, 2023 9.36%
Jun 30, 2023 -7.52%
Mar 31, 2023 32.30%
Dec 31, 2022 -39.89%
Sep 30, 2022 20.84%
Jun 30, 2022 17.28%
Mar 31, 2022 5.84%
Dec 31, 2021 66.82%
Sep 30, 2021 26.31%
API Access

Ligand Pharmaceuticals Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=LGND&period=max&api_key=YOUR_API_KEY